Skip to Content

93 154 (Ticlopidine Hydrochloride 250 mg)

Pill with imprint 93 154 is White, Elliptical / Oval and has been identified as Ticlopidine Hydrochloride 250 mg. It is supplied by Teva Pharmaceuticals USA.

Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 154

Ticlopidine hydrochloride 250 mg 93 154 Front
Ticlopidine hydrochloride 250 mg 93 154 Back
Ticlopidine hydrochloride 250 mg 93 154
Ticlopidine hydrochloride 250 mg 93 154

Ticlopidine Hydrochloride

93 154
250 mg
15.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00093-0154 Teva Pharmaceuticals USA, Inc.
42291-0803 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.